Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm
- PMID: 37736856
- PMCID: PMC10904402
- DOI: 10.1007/s40618-023-02182-5
Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm
Abstract
Purpose: Indeterminate cytology still puzzles clinicians, due to its wide range of oncological risks. According to the Italian SIAPEC-IAP classification, TIR3B cytology holds up to 30% of thyroid cancer, which justifies the surgical indication, even if more than half of cases do not result in a positive histology. The study aim is to identify potential clinical, ultrasound or cytological features able to improve the surgical indication.
Methods: Retrospective analysis. A consecutive series of TIR3B nodules referred to the Endocrine Unit of Careggi Hospital from 1st May 2014 to 31st December 2021 was considered for the exploratory analysis (Phase 1). Thereafter, a smaller confirmatory sample of consecutive TIR3B diagnosed and referred to surgery from 1st January 2022 to 31st June 2022 was considered to verify the algorithm (Phase 2). The main clinical, ultrasound and cytological features have been collected. A comprehensive stepwise logistic regression was applied to build a prediction algorithm. The histological results represented the final outcome.
Results: Of 599 TIR3B nodules referred to surgery, 451 cases were included in the exploratory analysis. A final score > 14.5 corresponded to an OR = 4.98 (95% CI 3.24-7.65, p < 0.0001) and showed a PPV and NPV of 57% and 79%, respectively. The Phase 2 analysis on a confirmatory sample of 58 TIR3B cytology confirmed that a threshold of 14.5 points has a comparable PPV and NPV of 53% and 80%, respectively.
Conclusions: A predictive algorithm which considers the main clinical, US and cytological features can significantly improve the oncological stratification of TIR3B cytology.
Keywords: Algorithms; Cytology; Indeterminate cytology; Thyroid cancer.
© 2023. The Author(s).
Conflict of interest statement
M.M. is an associate of JENI Editorial Board (for the Andrology section). All the other authors have nothing to disclose.
Figures


Similar articles
-
Predictors of malignancy in high-risk indeterminate (TIR3B) cytopathology thyroid nodules.J Endocrinol Invest. 2020 Aug;43(8):1115-1123. doi: 10.1007/s40618-020-01200-0. Epub 2020 Feb 25. J Endocrinol Invest. 2020. PMID: 32100197
-
Testing for Afirma in Thyroid Nodules with High-Risk Indeterminate Cytology (TIR3B): First Italian Experience.Endocr Pathol. 2020 Mar;31(1):46-51. doi: 10.1007/s12022-020-09604-7. Endocr Pathol. 2020. PMID: 31960284
-
Indeterminate thyroid nodules (TIR3A/TIR3B) according to the new Italian reporting system for thyroid cytology: A cytomorphological study.Cytopathology. 2019 Sep;30(5):475-484. doi: 10.1111/cyt.12732. Epub 2019 Jun 25. Cytopathology. 2019. PMID: 31112332
-
Outcome and diagnostic reproducibility of the thyroid cytology "indeterminate categories" SIAPEC/SIE 2014 in a consecutive series of 302 cases.J Endocrinol Invest. 2021 Apr;44(4):803-809. doi: 10.1007/s40618-020-01377-4. Epub 2020 Aug 14. J Endocrinol Invest. 2021. PMID: 32797379 Free PMC article.
-
Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.Thyroid. 2019 Feb;29(2):222-228. doi: 10.1089/thy.2018.0394. Epub 2018 Dec 21. Thyroid. 2019. PMID: 30426887
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous